U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06847165) titled 'Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure' on Feb. 16.
Brief Summary: This is an open-label trial of trigeminal nerve stimulation (TNS) for children aged 8-12 years with attention deficit hyperactivity disorder (ADHD) putatively due to prenatal alcohol exposure (PAE). TNS has been successful in treating pediatric ADHD generally and it is US Food and Drug Administration (FDA)-cleared for this condition. But this will be the first time it is tried for ADHD specifically associated with PAE. In TNS, a weak electric current is applied to the child's forehead overnight while sleeping to gently stimulate the ...